These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 25736433)

  • 1. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
    Koloski NA; Jones M; Young M; Talley NJ
    Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.
    Wong RK; Palsson OS; Turner MJ; Levy RL; Feld AD; von Korff M; Whitehead WE
    Am J Gastroenterol; 2010 Oct; 105(10):2228-34. PubMed ID: 20502449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constipation and Constipation-predominant Irritable Bowel Syndrome: A Comparative Study Using Rome III Criteria.
    Rajindrajith S; Devanarayana NM; Benninga MA
    J Pediatr Gastroenterol Nutr; 2017 May; 64(5):679-684. PubMed ID: 27403609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
    Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
    Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
    World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and anorectal manometry profile of patients with functional constipation and constipation-predominant irritable bowel syndrome.
    Goyal O; Bansal M; Sood A
    Indian J Gastroenterol; 2019 Jun; 38(3):211-219. PubMed ID: 31240564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences between IBS-C and FC with regards to symptomatology, sleep quality and psychological attributes.
    Chen HD; Bair MJ; Chang WC; Hsu CS; Wong MW; Hung JS; Liu TT; Yi CH; Lei WY; Chen CL
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):75-80. PubMed ID: 30922615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.
    Bouchoucha M; Devroede G; Mary F; Bon C; Bejou B; Benamouzig R
    Dig Dis Sci; 2018 Jul; 63(7):1763-1773. PubMed ID: 29492744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
    Black CJ; Yiannakou Y; Guthrie EA; West R; Houghton LA; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):372-381. PubMed ID: 33110014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Black CJ; Houghton LA; Ford AC
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study.
    Bellini M; Usai-Satta P; Bove A; Bocchini R; Galeazzi F; Battaglia E; Alduini P; Buscarini E; Bassotti G;
    BMC Gastroenterol; 2017 Jan; 17(1):11. PubMed ID: 28088179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
    J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.
    Heidelbaugh JJ; Stelwagon M; Miller SA; Shea EP; Chey WD
    Am J Gastroenterol; 2015 Apr; 110(4):580-7. PubMed ID: 25781368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation.
    Whitehead WE; Palsson OS; Simrén M
    Neurogastroenterol Motil; 2016 Jun; 28(6):783-92. PubMed ID: 27214096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.